Financials MagForce AG Xetra

Equities

MF6

DE000A0HGQF5

Biotechnology & Medical Research

End-of-day quote Xetra 06:00:00 2022-08-10 pm EDT 5-day change 1st Jan Change
0.1165 EUR -.--% Intraday chart for MagForce AG -.--% -.--%

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales 1 0.5248 0.7161 0.0672 1.058 1.502 1.077
EBITDA 1 -6.436 -9.288 -6.505 -5.561 -6.568 -5.766
EBIT 1 -7.342 -9.831 -7.103 -6.203 -7.233 -6.444
Operating Margin -1,399.09% -1,372.86% -10,569.46% -586.3% -481.5% -598.25%
Earnings before Tax (EBT) 1 -7.231 -7.465 4.358 -8.731 14.75 -10.57
Net income 1 -7.231 -7.465 4.358 -8.731 14.75 -10.57
Net margin -1,377.97% -1,042.45% 6,485.2% -825.17% 981.61% -981.7%
EPS 2 -0.2822 -0.2833 0.1647 -0.3151 0.5023 -0.3533
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/30/17 5/3/18 6/20/19 7/9/20 6/30/21 6/30/22
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 - 4.75 14.4 16.5 21.1 25.5
Net Cash position 1 0.61 - - - - -
Leverage (Debt/EBITDA) - -0.5111 x -2.211 x -2.968 x -3.216 x -4.427 x
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) -37.5% -51.8% 27.8% -53.1% 58.7% -33.9%
ROA (Net income/ Total Assets) -20.3% -29% -15% -10.5% -8.84% -6.27%
Assets 1 35.56 25.7 -29.04 83.09 -166.8 168.6
Book Value Per Share 2 0.6100 0.5000 0.6900 0.5300 1.210 0.9000
Cash Flow per Share 2 0.0200 0.0300 0.0600 0.0100 0.0600 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 6/30/17 5/3/18 6/20/19 7/9/20 6/30/21 6/30/22
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise